Ophelia Health

Ophelia Health, Inc.Ophelia Health, Inc. provides telehealth services to treat opioid use disorder. The company was founded by Elliot Barbernell and Zack Gray. Its headquarters is located in New York, US.Ophelia offers telehealth services focused on the treatment of opioid use disorder, primarily through the prescription of Suboxone® (buprenorphine and naloxone). Patients connect with licensed clinicians via Zoom for consultations and prescriptions, providing necessary support for those managing opioid dependence. The service caters to a diverse clientele, including those on Medicaid and private insurance, with minimal out-of-pocket costs, typically less than USD 10 a month.Ophelia’s revenue model is subscription-based, covering clinician visits, Suboxone management, and ongoing support from care teams. The company collaborates with many health insurers, including Medicaid, to expand its market reach. Most patients incur low monthly fees around USD 10 for comprehensive telehealth services, enabling consistent client transactions and access to essential care without significant financial burden.00 mn, Ophelia Health, Inc. plans to expand its treatment programs to serve more patients and clinicians throughout the United States. Ophelia aims to increase its geographic footprint and patient reach significantly in the upcoming years.

1. Series B

   Dec 9, 2021

   Amount

   $50M

   Investors

   Locked

2. Series A

   Apr 5, 2021

   Amount

   $15M

   Investors

   Locked

3. Seed

   Apr 23, 2020

   Amount

   $3.4M

   Investors

   Locked